Cited by 1,107Nanoparticle-Based Drug DeliveryBarrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.

Nanoparticulate systems for brain delivery of drugs.

Kreuter, Jörg·2001·Advanced Drug Delivery Reviews

DOI 10.1016/s0169-409x(00)00122-8

Open this paper in CoChat — free account

Abstract

The blood--brain barrier (BBB) represents an insurmountable obstacle for a large number of drugs, including antibiotics, antineoplastic agents, and a variety of central nervous system (CNS)-active drugs, especially neuropeptides. One of the possibilities to overcome this barrier is a drug delivery to the brain using nanoparticles. Drugs that have successfully been transported into the brain using this carrier include the hexapeptide dalargin, the dipeptide kytorphin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and doxorubicin. The nanoparticles may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. Intravenously injected doxorubicin-loaded polysorbate 80-coated nanoparticles were able to lead to a 40% cure in rats with intracranially transplanted glioblastomas 101/8. The mechanism of the nanoparticle-mediated transport of the drugs across the blood-brain barrier at present is not fully elucidated. The most likely mechanism is endocytosis by the endothelial cells lining the brain blood capillaries. Nanoparticle-mediated drug transport to the brain depends on the overcoating of the particles with polysorbates, especially polysorbate 80. Overcoating with these materials seems to lead to the adsorption of apolipoprotein E from blood plasma onto the nanoparticle surface. The particles then seem to mimic low density lipoprotein (LDL) particles and could interact with the LDL receptor leading to their uptake by the endothelial cells. After this the drug may be released in these cells and diffuse into the brain interior or the particles may be transcytosed. Other processes such as tight junction modulation or P-glycoprotein (Pgp) inhibition also may occur. Moreover, these mechanisms may run in parallel or may be cooperative thus enabling a drug delivery to the brain.

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(00)00122-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli
Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352

Show all 50 references

Research works printed but not linked: 6

Kreuter, 1994, Nanoparticles, Vol. 10, 165
Alyautdin, 1995, Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles, Eur. J. Pharm. Biopharm., 41, 44
Ramge, 2000, Polysorbate 80-coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human, bovine and murine primary brain capilary endothelial cells, Eur. J. Neuro., 12, 1935
Steiniger, 1999, The influence of polysorbate 80-coated nanoparticles on bovine brain capillary endothelial cells in vitro, Proc. Int. Symp. Control. Rel. Bioact. Mater., 26, 789
Fenart, 1999, Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood–brain barrier, J. Pharmacol. Exp. Ther., 291, 1017
Cecchelli, 1997, Receptor-mediated transcytosis of blood-borne molecules through blood–brain barrier endothelial cells: Drug targeting by endogenous transport routes, Proc. Intl. Symp. Control. Rel. Bioact. Mater., 24, 221

Sorted by citations

Items 901–1,000 of 1,000

Review of Motion Simulation of Particulate Matter in the Respiratory System and Further CFD Simulations on COVID-19
Zhu, D., Gires, E., Dong, H., Chen, A., & Ahmad, K. A. (2023) · Processes · doi:10.3390/pr11041281 · Cited by 3
A systematic review on application of nano-carriers loaded with drug in the treatment of neurological disorders
Shaikh, A. A., Anbhule, S. J., & Raykar, M. H. (2023) · Current Trends in Pharmacy and Pharmaceutical Chemistry · doi:10.18231/j.ctppc.2023.012 · Cited by 3
Role of Nanotechnology in Treating of Toxoplasma Gondii
(2023) · International Journal of Agriculture and Biosciences · doi:10.47278/book.zoon/2023.64 · Cited by 3
An overview of polymeric particulate drug delivery system formulations
ÇOMOĞLU, M. A. E. (2010) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000573 · Cited by 3
Formula-Driven, Size-Tunable Synthesis of PMMA Nanoparticles by Varying Surfactant Concentration
Kamras, B. L., Mirzanasiri, N., Korir, D., Mandal, S., Hariharakumar, S. L., Petros, R. A., Marpu, S. B., Simmons, D. P., & Omary, M. A. (2020) · Materials · doi:10.3390/ma13081834 · Cited by 3
Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and Challenges
Prakash, S., & Malhotra, M. (2008) · Drug Target Insights · doi:10.4137/dti.s378 · Cited by 3
Preparation of polyalkylcyanoacrylate nanoparticles with various morphologies
Xu, Q., Li, H., & Wang, G.-C. (2011) · Chinese Journal of Polymer Science · doi:10.1007/s10118-011-1033-y · Cited by 3
Chemical Immersion Coatings to Improve Biological Degradability of Magnesium Substrates for Potential Orthopaedic Applications
Brundavanam, S. (2014) · International Journal of Biomedical Materials Research · doi:10.11648/j.ijbmr.20140202.11 · Cited by 3
Tobacco smoke modulates ozone-induced toxicity in rat lungs and central nervous system
Bhoopalan, V., Han, S. G., Shah, M. M., Thomas, D. M., & Bhalla, D. K. (2013) · Inhalation Toxicology · doi:10.3109/08958378.2012.751143 · Cited by 3
Colorimetric detection of vesicle rupture by attack of Ag nanoparticles
Shin, S.-H., & Kim, Y. (2012) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-012-0102-4 · Cited by 3
Nanotherapeutics Magic Bullets- a Boon or Bane to Human Health
Gauri, B. (2012) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000142 · Cited by 3
Synthesis, characterization and ultrasonic study of aqueous suspensions containing polymeric nano particles of poly (L-lactide)
Swarnavalli, G. C. J., Kannappan, V., Roopsingh, D., Joseph, V., Sornadurai, D., & Paul, V. T. (2015) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2015.08.011 · Cited by 3
Determination of 6258-70, a new semi-synthetic taxane, in rat plasma and tissues: Application to the pharmacokinetics and tissue distribution study
Zhao, S., Zhang, Y., Ju, P., Gu, L., Zhuang, R., Zhao, L., Tang, X., Kai-shun, B., & Chen, X. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2016.02.003 · Cited by 3
Drug delivery nanosystems for neural regenerative medicine
Kecel‐Gunduz, S., Bıçak, B., & Özel, A. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820223-4.00004-8 · Cited by 3
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art
(2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681084930117020011 · Cited by 4
Particle Toxicities
Madl, A. K., Sun, X., Silva, R. M., Kadir, T., & Pinkerton, K. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02084-5 · Cited by 3
Nanotechnology for Improved Drug Bioavailability
Yliperttula, M. L., & Urtti, A. O. (2008) · Methods and principles in medicinal chemistry · doi:10.1002/9783527623860.ch22 · Cited by 3
Health Effects of Inhaled Engineered Nanoscale Materials
Madl, A. K., & Pinkerton, K. E. (2008) · Wiley eBooks · doi:10.1002/9780470396612.ch15 · Cited by 3
Nanoparticles for the Treatment of A lzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives
Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0122 · Cited by 3
Iron Chelation and Nanoparticle Target Delivery in the Development of New Multifunctional disease-modifying Drugs for Alzheimer‘s Disease
Liu, G., Men, P., Zhu, X., & Perry, G. L. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.32 · Cited by 4
Magnetic Nanomaterial‐based Anticancer Therapy
Enrico, C. (2016) · doi:10.1002/9781119241966.ch5 · Cited by 3
Surface-modified PLGA nanoparticles for targeted drug delivery to neurons
Li, J. (2012) · doi:10.31390/gradschool_theses.4051 · Cited by 3
Solvent-free beta-carotene nanoparticles for food fortification
Huynh, P. T. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3np236k · Cited by 3
Prevention of NMDA receptor sensitization by neurotoxic β-amyloid through polyphosphate coacervation
Müller, W. E. G., Perović‐Ottstadt, S., Dobmeyer, R., Neufurth, M., Nassabi, H., Muñoz‐Espí, R., Ushijima, H., Schröder, H. C., & Wang, X. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119578 · Cited by 2
CNT PLATFORMS BIOCOMPATIBILITY AND IMPACT ON NEURONAL PERFORMANCE
(2012) · CRC Press eBooks · doi:10.1201/b11835-21 · Cited by 1
Capsaicin Nanoparticles as Therapeutic Agents against Gliomas
Martínez-Benavidez, E., Higuera-Ciapara, I., Herrera-Rodríguez, S. E., Lugo-Melchor, O., Goycoolea, F., & Jazo, F. G. (2021) · Nano Biomedicine and Engineering · doi:10.5101/nbe.v13i4.p433-445 · Cited by 2
Crossing Blood-Brain Barrier with Nano-drug Carriers for Treatment of Brain Tumors: Advances and Unmet Challenges
Bhunia, S., & Chaudhuri, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101925 · Cited by 3
FORMULATION OF NANOSTRUCTURED LIPID CARRIERS OF HALOPERIDOL PREPARED BY USING CLARIFIED BUTTER
Hardikar, S., ANSARI, D. M. A., & PATIL, N. A. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i2.46759 · Cited by 2
Comparative Analysis of the Interaction of Silver Nanoparticles with Hexokinase from Trypanosoma brucei and Humans
Mlozen, M., van Marwijk, J., Wilhelmi, B., & Whiteley, C. G. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s401319 · Cited by 2
Protein and Peptide-based Nanoparticles as an emerging strategy to tackle cancer drug resistance
Abdellatif, M., Hassanin, I. A., Mahmoud, Y. S., Teleb, M., Bekhit, A. A., & Khattab, S. N. (2023) · Alexandria Journal of Science and Technology · doi:10.21608/ajst.2023.206740.1008 · Cited by 2
Development and evaluation of loperamide hydrochloride loaded chitosan nanoformulation for neurotoxic effects on mice
Yadav, M., Parle, M., Sharma, N., Jindal, D. K., Joshi, K., Raina, N., & Gupta, T. (2023) · Polymer Bulletin · doi:10.1007/s00289-023-04952-w · Cited by 2
Role of nanotechnology in therapeutics and diagnosis of Alzheimer’s disease
Sundaram, D. P., Govindaswamy, S., Mathiazhagan, S., & Venugopal, J. (2024) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v7i1.225 · Cited by 2
Nose-to-Brain Drug Delivery Strategies for the Treatment of Neurological Disorders
Prabakaran, A., Bhatane, D., & Alexander, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_17 · Cited by 2
Advances in Nanotechnology for Drug Delivery Modulation in Neurodegenerative Diseases
Abdel-Dayem, D., Emara, H. M., Elshafey, B., & Salama, M. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_9 · Cited by 2
Using Immunoliposomes as Carriers to Enhance the Therapeutic Effectiveness of Macamide N-3-Methoxybenzyl-Linoleamide
Vera-López, K. J., Zenteno, M. A., Dávila-Del-Carpio, G., & Nieto-Montesinos, R. (2025) · Neurology International · doi:10.3390/neurolint17030038 · Cited by 2
Polimerik nanopartikuler ilaç taşıyıcı sistemlerde yüzey modifikasyonu
HASCİCEK, S.-T. C. T. (2009) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000522 · Cited by 2
Feature Article: Polymeric Nanoparticulate Drug Delivery Through The Blood Brain Barrier
Roney, C. A., Kulkarni, P. V., Arora, V., Bennett, M., Antich, P. P., Bonte, F. J., Wu, A., Nadagouda, M. N., Manohar, S. K., Sairam, M., et al. (2005) · Polymer News · doi:10.1080/00323910500290374 · Cited by 2
Novel PLGGE graft polymeric micelles for doxorubicin delivery
Yu, Z., He, B., Sheng, M., Wang, G., & Gu, Z. (2012) · Chinese Science Bulletin · doi:10.1007/s11434-012-5307-8 · Cited by 2
Human Serum Albumin-grafted Cationic Solid Lipid Nanoparticles for Delivery of Nevirapine in Vivo
Yang, J., Kuo, Y., & Chung, J.-F. (2011) · Cited by 2
Nanoparticulate Systems for Central Nervous System Drug Delivery
Olivier, J., & de Oliveira, M. P. (2007) · Drugs and the pharmaceutical sciences · doi:10.1201/9781420008449.ch17 · Cited by 2
Delivery to the brain
Yamamoto, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-56336-1.50042-4 · Cited by 3
Compilation and Analysis of Enzymes, Engineered Antibodies, and Nanoparticles Designed to Interfere with Amyloid‐β Aggregation
Zhao, J., Ma, B., & Nussinov, R. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600093 · Cited by 2
Nanotoxicology
Lowe, A. C., Hunter-Ellul, L., & Wilkerson, M. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5034-4_22 · Cited by 2
Nanodiamond Particles
Schrand, A. M., Hens, S. A. C., & Shenderova, O. A. (2012) · The electrical engineering handbook/Electrical engineering handbook series/Electrical engineering handbook · doi:10.1201/b11930-33 · Cited by 2
"Advances in Magnetic Nanoparticles for Biomedical Applications"
Sathish, T. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.46.007354 · Cited by 2
Effect of surfactants on the therapeutic efficacy of atovaquone nanosuspensions against acute and reactivated murine toxoplasmosis
Shubar, H. M. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5393 · Cited by 2
PEGylated Polymer‐Based Nanoparticles for Drug Delivery to the Brain
Kim, H. R., Andrieux, K., & Couvreur, P. (2007) · Wiley eBooks · doi:10.1002/9783527631117.ch13 · Cited by 3
Application of Poly(γ‐Glutamic Acid)‐Based Nanoparticles as Antigen Delivery Carriers in Cancer Immunotherapy
Matsuo, K., Okada, N., & Nakagawa, S. (2013) · Wiley eBooks · doi:10.1002/9781118451915.ch28 · Cited by 2
From Polymer Chemistry and Physicochemistry to Nanoparticulate Drug Carrier Design and Applications
Fattal, E., Labarre, D., & Vauthier, C. (2003) · CRC Press eBooks · doi:10.1201/9780203913338.ch26 · Cited by 2
Targeting Drugs into the Central Nervous System
Prókai, L. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4627-3_19 · Cited by 2
DESENVOLVIMENTO DE NANOPARTÍCULAS DE PLA E PLA-PEG PARA ADMINISTRAÇÃO INTRANASAL DE ZIDOVUDINA
Mainardes, R. M. (2007) · Americanae (AECID Library) · Cited by 2
Cerium oxide nanoparticles synthesized via green route exhibit neuroprotective effects in Alzheimer’s-induced Albino Wistar rats
Sriramcharan, P., Ahmed, S. S., Natarajan, J., Kumar, R. R., Antony, J., Kumar, A. P., Anjali, P., Nagaraju, G., Shah, R. M., & Madar, I. H. (2025) · 3 Biotech · doi:10.1007/s13205-025-04563-4 · Cited by 1
Mapping two decades of nanomaterials research in glioblastoma: trends, networks, and translational insights
Wang, G., Liu, M., Wang, W., & Wang, B. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04691-x · Cited by 1
Emerging use of bio-nanomaterials for brain pathologies
Noor, L., Singh, M. S., Upadhyay, A. K., & Joshi, V. (2026) · Nanotoxicology · doi:10.1080/17435390.2026.2634094 · Cited by 1
Polylactic acid nanoparticles targeted to brain microvascular endothelial cells
Huafang, W., Yu, H., Wangqiang, S., & Xie, C. (2005) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/bf02896158 · Cited by 1
Foam droplet separation for nanoparticle synthesis
Tyree, C. A., & Allen, J. O. (2007) · Journal of Nanoparticle Research · doi:10.1007/s11051-007-9280-0 · Cited by 1
Nanocomposites for Regenerative Medicine
Hoshi, R. A., Webb, A. R., Qiu, H., & Ameer, G. A. (2010) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-90-481-8790-4_10 · Cited by 1
Nanobiotechnology: A new generation of biomedicine - Innovative nanotechnology in key areas of biomedical engineering and cancer therapy
Tosi, G., Ruozi, B., Badiali, L., Bondioli, L., Belletti, D., Forni, F., & Vandelli, M. A. (2012) · IRIS UNIMORE (University of Modena and Reggio Emilia) · doi:10.4032/9789814267359 · Cited by 1
Drug delivery system for active brain targeting
Mei, X.-G., & YANG, M.-Y. (2007) · Elsevier eBooks · doi:10.1533/9781845693077.4.404 · Cited by 1
Nanotecnología y cáncer: aplicación al tratamiento de tumores cerebrales
Lemus, M. A. A., & López, T. (2012) · Cited by 1
Biodegradable Surfactants For Advanced Drug Delivery Strategies
Hoennscheidt, C., & Krull, R. (2013) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1087138 · Cited by 1
Drug delivery systems as advanced nanotechnology
Madkour, L. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819777-6.00012-3 · Cited by 1
Advances Toward the Development of New Therapeutic Strategies Targeting Acetylcholinesterase and Its Remediation Processes
de Castro, A. A., de Assis, L. C., Gajo, G. C., Ramalho, T. C., & Porta, F. A. L. (2021) · Engineering materials · doi:10.1007/978-3-030-62226-8_21 · Cited by 1
Nanopharmacokinetics: routes of administration and predictive models for nanopharmacokinetics
Rohiwal, S. S., Tiwari, A. P., & Ellederová, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85050-6.00012-8 · Cited by 1
Polymeric Nanoparticles to Target Glioblastoma Tumors
Patil, P. H., Pardeshi, C. V., & Surana, S. J. (2022) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-031-14848-4_12 · Cited by 1
Application of nanochitosan in the preservation of meat
Bhowmik, S., Agyei, D., & Ali, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85593-8.00032-1 · Cited by 1
Lipid nanocarriers for the delivery of drugs to the nervous system
Basha, M., AbouSamra, M. M., & Kamel, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95171-5.00005-4 · Cited by 1
Interdigitation of lipids for vesosomal formulation of ergotamine tartrate with caffeine: a futuristic trend of intranasal route
Dali, P., & Shende, P. K. (2023) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2023.2301018 · Cited by 1
In-vitro cytotoxic studies of 1-hexylcarbamoyl-5-fluorouracil encapsulated nanogels in BMG-1 cells
Budhiraja, S., Yadav, A., Sharma, R. K., & Sharma, R. K. (2024) · Chemical Biology Letters · doi:10.62110/sciencein.cbl.2024.v11.655 · Cited by 1
Organelle-level toxicity of nanometals relevant to titanium implants. Original research and comprehensive literature overview
Zaimoğlu, M., Seçinti, K. D., Altinoz, M. A., Bozkurt, M., Eroğlu, Ü., Özpişkin, Ö. M., Mammadkhanlı, O., Bayatli, E., Caglar, Y. S., & Attar, A. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102612 · Cited by 1
Modification of Nano-sized Materials for Drug Delivery
Xu, T., Nichols, H. L., Zhang, N., & Wen, X. (2009) · Springer eBooks · doi:10.1007/978-3-540-49661-8_15 · Cited by 1
PREPARATION OF TEMOZOLOMIDE LOADED POLY(BUTYL CYANOACRYLATE) NANOPARTICLE FOR CHEMOTHERAPY OF BRAIN TUMOR.
Yamamoto, H., Bootz, A., Kreuter, J., & Wolfgang, J. (2005) · Cited by 1
Nanoparticle–Tissue Interaction
Wu, X., & Lu, Z. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_10 · Cited by 1
POLY ALKYL CYANOACRYLATE NANOPARTICLES AS DELIVERY VEHICLE IN COMBATING DISEASES
Mandal, A. K. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/7136990 · Cited by 1
Nano-pharmacokinetics and cancer theranostics
Parihar, V. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85050-6.00014-1 · Cited by 1
Bioactive Lipids
Vázquez, L., Corzo‐Martínez, M., Arranz‐Martínez, P., Barroso, E., Reglero, G., & Torres, C. F. (2017) · Reference series in phytochemistry · doi:10.1007/978-3-319-54528-8_58-1 · Cited by 1
Is Bionanotechnology a Panacea?
Papazoglou, E. S., & Parthasarathy, A. (2007) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-01618-9_7 · Cited by 1
An investigation of the use of dendrimer-based carrier to cross cellular barrier
Teow, H. M. (2011) · CLOK (University of Central Lancashire) · Cited by 1
Nanotechnologies for Targeted Delivery of Drugs
Brož, P., & Hunziker, P. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0111 · Cited by 1
Functional Nanomaterials for Biomedical Research: Focus on Bio‐Functionalization, Biosynthesis, and Biomedical Applications
Veerapandian, M., Sadhasivam, S., Subbiah, R., & Yun, K. (2013) · Wiley eBooks · doi:10.1002/9781118451915.ch4 · Cited by 1
Biomimetic Nanoparticles Providing Molecularly Defined Binding Sites – Protein‐Featuring Structures versus Molecularly Imprinted Polymers
Borchers, K., Genov, S., Gruber‐Traub, C., Niedergall, K., Plankalayil, J., Pufky‐Heinrich, D., Riegler, J., Schreiber, T., Tovar, G. E. M., Weber, A., et al. (2009) · doi:10.1002/9783527627011.ch2 · Cited by 1
Polymer Nanoparticles and Their Cellular Interactions
Mailänder, V., & Landfester, K. (2011) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0255 · Cited by 1
Radiopaque Polymeric Nanoparticles for X ‐Ray Medical Imaging
Margel, S., Galperin, A., Aviv, H., Bartling, S. H., & Kiessling, F. M. (2011) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0256 · Cited by 1
Preparation of injectable sustained-release nanoparticles carrying brain-derived neurotrophic factor and evaluation of their drug releasing characteristics
Shi, G. (2008) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2008.00538 · Cited by 1
Potential pathophysiological mechanisms of ultrafine particle toxic effects in humans
Jović-Stošić, J., & Jovašević-Stojanović, M. (2008) · Chemical Industry and Chemical Engineering Quarterly · doi:10.2298/ciceq0801047j · Cited by 1
Polysaccharide-based Polyion Complex Micelles as New Delivery Systems for Hydrophilic Cationic Drugs
Soliman, G. M. (2009) · doi:10.71781/4636 · Cited by 1
Ambient air pollution and brain cancer mortality Roberta McKean-Cowdin Eugenia E. Calle John M. Peters *
Henley, J., Thurston, G. D., Thun, M. J., & Preston‐Martin, S. (2009) · Cited by 1
Immunociblage du cerveau par des nanocapsules lipidiques
Béduneau, A. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
APPLICATION OF NANOSCALE POLYMER COLLOID CARRIERS FOR TARGETED DELIVERY OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR THROUGH THE BLOOD-BRAIN BARRIER IN EXPERIMENTAL PARKINSONISM
Myu, K., Alyautdin, R. N., Rwal, W.-S., Mnk, N.-A., Аhmad, A., Норита, С., & Dydykin, S. S. (n.d.) · CyberLeninK (CyberLeninka) · Cited by 1
Toxicity and Safety Evaluation of Lipid‐Based Nanoparticles for Brain Delivery
Patel, M., & Patel, P. R. (2021) · Wiley eBooks · doi:10.1002/9781119769897.ch10 · Cited by 1
Pharmaceutical Nanocarriers: Disposition
Costa, T. D., Carreño, F. O., & Haas, S. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_112-1 · Cited by 1
Nanoparticles as Drug Delivery Systems for the Brain
Benita, S. (2005) · CRC Press eBooks · doi:10.1201/9781420027990-24 · Cited by 1
Doxorubicin-Polysorbate 80 Conjugates: Targeting Effective and Sustained Delivery to the BrainPreprint
Sekar, R. P., Leena, S. S., Deepthi, A., Resmi, A. N., Jayasree, R. S., & Jayakrishnan, A. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-gspzt
The Interaction of Targeted and Non-Targeted Nanoparticles with Cells and Model Membranes.
Leroueil, P. R. (2008) · Deep Blue (University of Michigan) · Cited by 1
Hypoxia/Reoxygenation Stress Modulates Atorvastatin Transport at the Blood-Brain Barrier: A Role for Organic Anion Transporting Polypeptide
Thompson, B. J. (2014) · UA Campus Repository (The University of Arizona)
Development of nanovectors for the targeted drug delivery of antimalarials
Urbán, P. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Adjuvant Approaches for Preventing Brain Metastases
Menter, D. G., Sabichi, A. L., & Lippman, S. M. (2004) · doi:10.1002/9780470753064.ch26
Challenges for PET Neuroimaging of Depressive Disorders
Donald, & Philip, W. J. B. (2010) · Sciyo eBooks · doi:10.5772/9881
Transporterhypothese der Pharmakoresistenz von Epilepsien
Potschka, H. (2010) · Clinical Epileptology · doi:10.1007/s10309-010-0105-2
SYNTHESIS AND CHARACTERIZATION OF POLYMERIC MICELLE DELIVERY SYSTEM AS A DRUG AND
Nice, J. B. (2014) · TigerPrints (Clemson University)

Authors: Kreuter, J.
Affiliations: Goethe University Frankfurt (DE)
Corresponding author: Kreuter, Jörg
Venue: Advanced Drug Delivery Reviews
Publisher: Elsevier BV
Published: 2001-03
Volume: 47
Issue: 1
Pages: 65-81
ISSN: 0169-409X (ISSN-L)
DOI: 10.1016/s0169-409x(00)00122-8
OpenAlex: W2072229818
Cited by: 1,107
References: 50
Citations by year: 2026: 15 · 2025: 20 · 2024: 26 · 2023: 39 · 2022: 32 · 2021: 43 · 2020: 47 · 2019: 40 · 2018: 47 · 2017: 53 · 2016: 63 · 2015: 57 · 2014: 55 · 2013: 65 · 2012: 76
FWCI: 1.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advanced Drug Delivery Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, nanoparticle drug delivery, brain drug delivery, apolipoprotein E, glioblastoma, doxorubicin, neuropeptides, P-glycoprotein inhibition, tight junction modulation, transcytosis, central nervous system drugs
MeSH terms: Animals, Antineoplastic Agents, Blood-Brain Barrier, Brain, Brain Neoplasms, Capsules, Cells, Cultured, Doxorubicin, Drug Carriers, Endothelium, Vascular, Humans, Male, Polysorbates, Surface-Active Agents, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticulate systems for brain delivery of drugs.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks